Topiramate USP For Compounding (API)

Topiramate USP for Compounding (API) is an active pharmaceutical ingredient used to create personalized medications for managing epilepsy and migraine prophylaxis. Known for its anticonvulsant properties, it helps control seizures and reduce the frequency of migraines by stabilizing electrical activity in the brain. In a compounding setting, pharmacists can tailor specific dosages and formulations to meet unique patient needs, especially for those who experience adverse effects with standard treatments or require customized dosage forms for effective management.

Topiramate USP active pharmaceutical ingredients (API) is a chemical substance used as the main active ingredient in pharmaceutical drugs, specifically in the medication topiramate. Topiramate is a prescription medication primarily used for the treatment of epilepsy and also approved for the prevention of migraines. The API is responsible for the therapeutic effects of the medication, meaning it is the component that produces the desired medical benefits in the body. Topiramate USP API is required to meet specific quality standards set by the US Pharmacopeia in terms of purity, potency, and quality in order to ensure the safety and effectiveness of the medication. 

Topiramate USP is a prescription medication primarily used for the treatment of seizures and prevention of migraines in adults and children. However, it can also be used off-label for other medical conditions or symptoms, such as mood disorders, obesity, and alcohol dependence. It may also be used in compounded medications to treat various conditions as determined by a healthcare provider. Compounding pharmacies may mix Topiramate USP with other ingredients to create customized formulations for patients who may have specific needs or preferences.

CAS Number: 97240-79-4

Property: Light Sensitive